High Flow Nasal Cannula Market (By Product Type: Single heated tube, Nasal cannula, Active humidifier, and Air blender; By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, and Others; By End-user: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Others; By Sales Channel: Direct Channel and Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts, 2023 - 2032
The global high flow nasal cannula market size reached USD 6 billion in 2022 and is projected to hit around USD 16.96 billion by 2032, registering a CAGR of 11% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. high flow nasal cannula market size Surpassed USD 1.32 billion in 2022 and is expected to reach around USD 3.81 billion by 2032, growing at a CAGR of 11.20% from 2023 to 2032.
North America is estimated to be the Largest Market for High Flow Nasal Cannula
The research report covers key trends and prospects of high flow nasal cannula products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, high flow nasal cannula market is conquered by North America owing to increasing prevalence of COVID-19, coupled with presence of key player in the countries of the region. Further, high prevalence of respiratory diseases as well as well-established healthcare facilities United States, Canada will augment target market industry in future. Asia Pacific is expected to register the fast growth rate, on account of expanding high flow nasal cannula manufacturing capacity, coupled with presence of leading companies in the countries of Asia Pacific.
Emerging applications of high flow nasal cannula are anticipated to create potential opportunities for the key players operating in global market. Due to outbreak of COVID-19, usage of high flow nasal cannula has been increased and has created tremendous opportunities for the major companies worldwide. Major players in the global market are focusing on the development of cost-effective advanced products to enhance market position. Increasing popularity and uptake of heated humidified high-flow nasal cannulas is key factor to propel industry growth over the forecast period 2023-2032. Further, ever-increasing number of respiratory disorders is growing at an alarming rate and in order treat such diseases adoption of high flow nasal cannula will continue to increase over next few years.
| Report Highlights | Details |
| Growth Rate from 2023 to 2032 | CAGR of 11% |
| Market Size in 2023 | USD 6.63 Billion |
| Market Size by 2032 | USD 16.96Billion |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Historic Data | 2020 to 2021 |
| Segments Covered | Product, Application, End-User, Sales Channel, Region |
| Companies Mentioned | Armstrong Medical Ltd, Salter Labs Inc, ResMed, Inc., Teleflex Inc, Vapotherm Inc., Becton Dickinson, and Company, Smiths Medical, Flexicare Medical Ltd, Teijin Pharma Limited |
COVID-19 Impact on Global High Flow Nasal Cannula Market
Outbreak of COVID-19 has affected most of industries operating across the globe, however COVID-19 is projected to have positive impact on the target market as the use of high flow nasal cannula is finding special significance. The outbreak of COVID-19 has forced the key operating players to launch innovative products. The centers for disease control and prevention have acknowledged oxygenation therapy by high flow nasal cannula as ideal and recommended for the treatment of COVID-19.
Crucial Factors Accountable for Market Growth Are:
Future of Global High Flow Nasal Cannula Market
Usage of high flow nasal cannula has been increased, due to ongoing COVID-19 pandemic that can have positive impact on the growth of the high flow nasal cannula industry over the forecast period. Additionally, growing attractiveness and uptake of heated humidified high-flow nasal cannulas across the world will enhance the target industry growth in the near future. Due to its excellent benefits heated humidified high-flow nasal cannulas are used to treat the patients with severe COVID-19.
Active humidifier Product Type Segment Estimated Foremost Market Stake In 2022
Active humidifier recorded the prime market share in the global high flow nasal cannula market by product type in 2020. Increased adoption of active humidifier in increased as it offers heated and humidified breathing gas which preserves the viscosity of the mucus which in turn maintains the ciliary activity. Nasal cannulaproduct type segment is predictable to rise at a noteworthy CAGR during the forecast time-frame.
Acute Respiratory Disorder Segment Estimated to Hold Major Market Share over the Forecast Period
Acute respiratory disorder application is anticipated to dominate the target market by application during the forecast period 2023-2032. Growing demand for high flow nasal cannula in order to treat acute respiratory disorders worldwide is propelling growth of the segment. Acute respiratory failure (ARF) is a critical condition HFNC therapy to the patients in the helps to decrease the intubation rate and increase the patient’s comfort level. However, chronic respiratory disorder segment is expected to rise at a significant CAGR during the forecast time-frame.
Hospitals and Clinics Segment is Predictable to Dominate the End-user Segment of High Flow Nasal Cannula Market Revenue
On the basis of end-user segment the global market is segregated into hospitals and clinics, long-term care centers, ambulatory care centers and others. Hospitals and clinics end-user segment is expected to dominate in terms of revenue over the forecast time frame. Ambulatory care centers end-user segment will expand at a significant CAGR during the forecast time-frame. The growth is attributed to owing to increasing demand for modern healthcare facilities that do not require overnight stay in developed countries across the globe which is in turn fueling the growth of the segment.
Distribution Channel Segment is expected to Dominate the Sales Channel Segment of High Flow Nasal Cannula Market Revenue
On the basis of the sales channel segment, the distribution channel end-user segment is expected to dominate in terms of revenue over the forecast time frame. Direct distribution sales channel segment will expand at a noteworthy CAGR during the forecast time-frame.
The companies focusing on research and development are expected to lead the global high flow nasal cannula market. Leading competitors contending in global high flow nasal cannula market are as follows:
In order to better recognize the current status of high flow nasal cannula, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the high flow nasal cannula market. Research study offers key insights on high flow nasal cannula market and research analysis of market size and trend for probable global market segments.
Major Market Segments Covered:
By Product Type
By Application
By End-user
By Sales Channel
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Product Types
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. High Flow Nasal Cannula Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on High Flow Nasal Cannula Market
5.1. Covid-19: High Flow Nasal Cannula Industry Impact
5.2. High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. High Flow Nasal Cannula Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Ever-increasing number of respiratory disorders
6.1.1.2. Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2. Market Restraints
6.1.2.1. Low rate of adoption of modern healthcare applications in developing countries
6.1.3. Market Opportunities
6.1.3.1. Increasing popularity and uptake of heated humidified high-flow nasal cannulas
Chapter 7. Global High Flow Nasal Cannula Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. High Flow Nasal Cannula Market Revenue by Market Players
7.1.1.2. High Flow Nasal Cannula Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End user
Chapter 8. Global High Flow Nasal Cannula Market, By Product Type
8.1. High Flow Nasal Cannula Market, by Product Type, 2023-2032
8.1.1. Single Heated Tube
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Nasal cannula
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Active humidifier
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. Air blender
8.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global High Flow Nasal Cannula Market, By End-user
9.1. High Flow Nasal Cannula Market, by End-user, 2023-2032
9.1.1. Hospitals and clinics
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Ambulatory care centers
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Long-term care centers
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global High Flow Nasal Cannula Market, By Application
10.1. High Flow Nasal Cannula Market, by Application, 2023-2032
10.1.1. Acute Respiratory Disorder
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Chronic Respiratory Disorder
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Acute Heart Failures
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global High Flow Nasal Cannula Market, By Sales Channel
11.1. High Flow Nasal Cannula Market, by Sales Channel, 2023-2032
11.1.1. Direct Channel
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Distribution Channel
11.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 12. Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2021-2032)
12.1.2. Market Revenue Forecast by End-user (2021-2032)
12.1.3. Market Revenue Forecast by Application (2021-2032)
12.1.4. Market Revenue Forecast by Sales Channel (2021-2032)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2032)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2032)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2021-2032)
12.2.2. Market Revenue Forecast by End-user (2021-2032)
12.2.3. Market Revenue Forecast by Application (2021-2032)
12.2.4. Market Revenue Forecast by Sales Channel (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2032)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2032)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2021-2032)
12.3.2. Market Revenue Forecast by End-user (2021-2032)
12.3.3. Market Revenue Forecast by Application (2021-2032)
12.3.4. Market Revenue Forecast by Sales Channel (2021-2032)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2032)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2032)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2032)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2021-2032)
12.4.2. Market Revenue Forecast by End-user (2021-2032)
12.4.3. Market Revenue Forecast by Application (2021-2032)
12.4.4. Market Revenue Forecast by Sales Channel (2021-2032)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2032)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2032)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2021-2032)
12.5.2. Market Revenue Forecast by End-user (2021-2032)
12.5.3. Market Revenue Forecast by Application (2021-2032)
12.5.4. Market Revenue Forecast by Sales Channel (2021-2032)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2032)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2032)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2032)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2032)
Chapter 13. Company Profiles
13.1. Armstrong Medical Ltd
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio, Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Becton Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio, Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fisher & Paykel Healthcare Limited
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio, Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Flexicare Medical Ltd
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio, Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Hamilton Medical AG
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio, Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. ResMed, Inc.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio, Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Salter Labs Inc
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio, Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Smiths Medical
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio, Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Teijin Pharma Limited.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio, Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Teleflex Inc
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio, Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. TNI Medical AG
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio, Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Vapotherm Inc.
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio, Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
